[1]
“Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience”, Reumatismo, vol. 57, no. 1, pp. 44–51, Mar. 2005, doi: 10.4081/reumatismo.2005.44.